Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/18/17 → 01/24/19 |
Funding
- Astex Pharmaceuticals Incorported: $6,625.00
A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) Versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Salman, Huda (CoPI)
Project: Research